SAB Biotherapeutics Overview
SAB Biotherapeutics Discounted Cash Flow
DCF Analysis for SABS.
Get informed when a big investor buys or sells
+ FollowFair Value
$0.07
Current Fair Value
$0.07
↓ 98.1% Downside
Overvalued by 98.1% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison